Amiloride for Resistant Hypertension
NCT02122731
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Type 2 Diabetes Mellitus
Microalbuminuria
Interventions
DRUG:
Amiloride
Sponsor
Ib Abildgaard Jacobsen